Amplicore Closes $4M Seed Funding

27 Mar, 2021

Amplicore Closes $4M Seed Funding
Photo by Valentin Farkasch on Unsplash

– Amplicore from Cincinnati develops minimally invasive therapeutic solutions for musculoskeletal diseases.
– The company closed its $4m seed round of funding.
– The round was led by Photon Fund, with participation from Industrial Technology Investment Corporation, Berkeley Catalyst Fund, and SVE Capital.
– The new investment will be used to complete the preclinical development of the company’s two leading products, AM3101 and AM1101, and position itself for the next round of financing.

North America Pharmaceuticals
Crunchbase icon

Content report

The following text will be sent to our editors: